Attività Correnti Cambiamento Data
AbbVie USD 37.48B 3.81B 2026-09
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Galectin Therapeutics USD 27.29M 1.83M 2024-06
Gilead Sciences USD 16.55B 4.02B 2026-09
Immunic USD 188.76M 165.89M 2026-03
Incyte USD 5.52B 505.2M 2026-09
Merck USD 38.94B 2.26B 2026-09